Skip to main content

MoneyWorks4Me

Vasundhara Rasayans - Quaterly Results

13 Nov 2026 Evaluate
A decrease of about -54.17% in the sales to Rs. 40.43 millions was observed for the quarter ended September 2026. The sales stood at Rs. 88.21 millions during the similar quarter previous year.Net Profit for the quarter ended September 2026 dipped to Rs. 0.39  millions from Rs. 20.58 millions  in the corresponding previous quarter.The company reported a degrowth in operating Profit to 1.48 millions from 29.82 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 40.43 88.21 -54.17 109.75 163.82 -33.01 357.23 339.90 5.10
Other Income 3.84 8.60 -55.35 7.53 15.44 -51.23 29.04 23.51 23.52
PBIDT 1.48 29.82 -95.04 12.02 39.92 -69.89 86.97 63.93 36.04
Interest 0.18 0.92 -80.43 0.66 2.28 -71.05 4.03 2.69 49.81
PBDT 1.30 28.90 -95.50 11.36 37.64 -69.82 82.94 61.24 35.43
Depreciation 0.77 1.09 -29.36 2.08 2.10 -0.95 4.30 3.57 20.45
PBT 0.53 27.81 -98.09 9.28 35.54 -73.89 78.64 57.67 36.36
TAX 0.14 7.23 -98.06 2.42 9.24 -73.81 20.74 15.21 36.36
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.11 0.01 -1200.00
PAT 0.39 20.58 -98.10 6.86 26.30 -73.92 57.90 42.46 36.36
Equity 31.78 31.78 0.00 31.78 31.78 0.00 31.78 31.78 0.00
PBIDTM(%) 3.66 33.81 -89.17 10.95 24.37 -55.06 24.35 18.81 29.44
Peers
Company Name CMP
Sun Pharma. Inds. 1897.75
Dr. Reddys Labs. 1389.45
Cipla 1411.95
Lupin 1987.70
Zydus Lifesciences 1198.30
View more..